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The HUGO Journal is focused on discoveries arising from the basic, clinical, and population explorations of the human genome, and genomes of organisms relevant to human health. As such we wish to publish primary research papers of the highest quality investigating topics in genomic medicine. In depth review articles on important topics pertinent to genomic medicine, human genetics, computational genomics, and genomic technologies will be featured. Because the HUGO Journal represents the voice of the Human Genome Organisation, we will be publishing key consensus reports and policy guidelines from HUGO Council and its subcommittees. Because of its history, The HUGO Journal will have the advantage of being fully indexed in PubMed from the outset thus providing visibility for all articles published in the journal.
Besides the current research articles, commentaries, and reviews, several new sections will be offered to enhance the exchange of information relevant to genomic scientists:
Data-bases: This section specifically encourages the publication of the description and utility of specific genomic databases. These reports will be fully indexed in PubMed.
Innovation Reports: These are short reports of \1,000 words that describe a specific finding of interest to the genomics community. The focus is on early publication of a highly innovative finding that may not have large scale validation. This includes case reports of unique genotypephenotype associations.
The HUGO Journal welcomes article submissions in many of the following categories:
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